swatski
Jetboaters Fleet Admiral 1*
- Messages
- 12,806
- Reaction score
- 18,573
- Points
- 822
- Location
- North Caldwell, NJ
- Boat Make
- Yamaha
- Year
- 2016
- Boat Model
- AR
- Boat Length
- 24
Okay, I’ll try to sound positive for a change, lol.
Aside from vaccines, which are definitely the best and sustainable long-term solution, there are a few things on the horizon that look very promising.
Some of it is gimmicky such as for example the so called RNAi strategies for suppressing host factors involved in viral response, but other new approaches are more straightforward. One is based on forcing your body to produce protective broadly-cross reactive antibodies neutralizing the virus.
One such particular development I think worth watching is coming from a company called Vir, their immuno genetics division headed by my former boss and a colleague, Skip Virgin.
Brilliant guy, he used to be flown by Bill Gates on his private jet to give him private lectures on viral immunity during Ebola, but I digress.
They are well funded, and have been in this business for a few years, their leadership is like a think-tank, lol. Currently, the one strategy I think may likely work is to introduce genetic material, essentially a “matrix” or mold, encoding protective antibodies, so that patients own cells can produce those virus-neutralizing antibodies.
The particular antibody they use is actually directed towards SARS1, but it cross reacts with the current COVID-19 coronavirus.
It’s like injecting antiserum to snake venom, or rabies, basically an iteration on preventative prophylaxis approaches used for decades.
Except here the production of those abs would be more stable with better pharmacokinetics. This could be a game changer BEFORE a vaccine, if it goes into production soon. But who knows.
He is a short press release on that particular new approach from them, nothing confidential there.
—
Aside from vaccines, which are definitely the best and sustainable long-term solution, there are a few things on the horizon that look very promising.
Some of it is gimmicky such as for example the so called RNAi strategies for suppressing host factors involved in viral response, but other new approaches are more straightforward. One is based on forcing your body to produce protective broadly-cross reactive antibodies neutralizing the virus.
One such particular development I think worth watching is coming from a company called Vir, their immuno genetics division headed by my former boss and a colleague, Skip Virgin.
Brilliant guy, he used to be flown by Bill Gates on his private jet to give him private lectures on viral immunity during Ebola, but I digress.
They are well funded, and have been in this business for a few years, their leadership is like a think-tank, lol. Currently, the one strategy I think may likely work is to introduce genetic material, essentially a “matrix” or mold, encoding protective antibodies, so that patients own cells can produce those virus-neutralizing antibodies.
The particular antibody they use is actually directed towards SARS1, but it cross reacts with the current COVID-19 coronavirus.
It’s like injecting antiserum to snake venom, or rabies, basically an iteration on preventative prophylaxis approaches used for decades.
Except here the production of those abs would be more stable with better pharmacokinetics. This could be a game changer BEFORE a vaccine, if it goes into production soon. But who knows.
He is a short press release on that particular new approach from them, nothing confidential there.
—
